XERS · Xeris Biopharma Holdings, Inc. · Executive Compensation
$11.13
+0.18 (+1.64%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$2.05B
Shares
182.32M
Volume · Oct 20
2.9M
Avg daily vol (3M)
2.29M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| John Shannon | Chief Executive Officer | $5,042,584 |
| Kevin McCulloch | President and Chief Operating Officer | $2,270,973 |
| Anh Nguyen | Chief Medical Officer | $2,000,648 |
| Beth P. Hecht | Chief Legal Officer and Corporate Secretary | $1,895,274 |
| Steven M. Pieper | Chief Financial Officer | $1,874,090 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Paul Edick | Former Chief Executive Officer | $6,826,608 |
| John Shannon | Chief Executive Officer | $3,827,109 |
| Beth P. Hecht | Chief Legal Officer and Corporate Secretary | $2,612,825 |
| Kevin McCulloch | President and Chief Operating Officer | $2,577,572 |
| Steven M. Pieper | Chief Financial Officer | $1,854,017 |
| Ken Johnson | Senior Vice President, Global Development and Medical Affairs | $1,058,429 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Paul Edick | Former Chief Executive Officer | $2,136,766 |
| Paul R. Edick | Chief Executive Officer | $2,136,766 |
| John Shannon | Chief Executive Officer | $1,848,153 |
| John P. Shannon | President and Chief Operating Officer | $1,848,153 |
| Steven M. Pieper | Chief Financial Officer | $1,611,142 |
| Beth P. Hecht | Chief Legal Officer and Corporate Secretary | $1,129,443 |
| Ken Johnson | Senior Vice President, Global Development and Medical Affairs | $720,967 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Paul Edick | Former Chief Executive Officer | $2,805,599 |
| Paul R. Edick | Chief Executive Officer | $2,805,599 |
| John Shannon | Chief Executive Officer | $1,530,218 |
| John P. Shannon | President and Chief Operating Officer | $1,530,218 |
| Beth Hecht | Chief Legal Officer and Corporate Secretary | $1,270,561 |
| Beth P. Hecht | Chief Legal Officer and Corporate Secretary | $1,270,561 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Paul R. Edick | Chief Executive Officer | $3,764,134 |
| Paul Edick | Chief Executive Officer | $3,764,134 |
| Barry Deutsch | Former Chief Financial Officer | $1,799,120 |
| John Shannon | President and Chief Operating Officer | $1,728,640 |
| John P. Shannon | President and Chief Operating Officer | $1,728,640 |
| Beth P. Hecht | Chief Legal Officer and Corporate Secretary | $1,424,994 |
| Beth Hecht | Chief Legal Officer and Corporate Secretary | $1,424,994 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Paul Edick | Chief Executive Officer | $2,264,349 |
| John Shannon | President and Chief Operating Officer | $1,436,428 |
| Beth Hecht | Chief Legal Officer and Corporate Secretary | $1,244,394 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Marla S. Persky | Lead Independent Director | Appointed | 2026-06-30 |
| John Shannon | Chairperson of the Board | Appointed | 2026-06-30 |
| Nerissa Kreher | Class III director | Appointed | 2026-06-30 |
| James Brady | director | Appointed | 2025-03-28 |
| Ricki Fairley | director | Resigned | 2025-03-28 |
| Anh Nguyen | Chief Medical Officer | Appointed | 2025-02-24 |
| Ken Johnson | Senior Vice President, Global Development and Medical Affairs | Retired | 2025-02-24 |
| Kevin McCulloch | President and Chief Operating Officer | Appointed | 2024-08-02 |
| John P. Shannon | member of the Board of Directors | Appointed | 2024-07-08 |
| John P. Shannon | CEO | Appointed | 2024-07-08 |
| Marla S. Persky | Chairperson of the Board | Appointed | 2024-07-08 |
| John Shannon | Chief Executive Officer | Appointed | 2024-07-08 |
| Paul R. Edick | Chairman of the Board of Directors | Resigned | 2024-07-08 |
| John Shannon | Class III director | Appointed | 2024-07-08 |
| Paul R. Edick | Chief Executive Officer | Resigned | 2024-07-08 |
| Marla S. Persky | Class III director | Appointed | 2024-06-05 |
| Ricki Fairley | Class III director | Appointed | 2024-06-05 |
| Paul R. Edick | Class III director | Appointed | 2024-06-05 |
| Ricki Fairley | Class III director | Appointed | 2023-03-29 |
Leadership
- John P. Shannon CEO, Board Member
- John Shannon CEO, Chairman, COO, Board Member
- Marla S. Persky Chairman
- Steven M. Pieper CFO
- Kevin McCulloch COO
- Beth P. Hecht General Counsel
- Dawn Halkuff Board Member
- Jeffrey W. Sherman Board Member
- John H. Johnson Board Member
- John Johnson Board Member
- Nerissa Kreher Board Member
- Paul Edick Board Member
- Ricki Fairley Board Member
Key facts
CIK
1867096
CUSIP
98422E103
13F (30d)
19 filings
19 filers
Visit website
Investor relations